Concerns about trace metal contamination in menstrual products have circulated widely in recent years, fueled partly by a 2024 study detecting arsenic, lead, and other metals in tampon materials. For the estimated 40+ million tampon users in the United States, understanding whether those detected levels translate to actual health risk has been the critical unanswered question — until now.
This FDA-conducted risk assessment, published in JAMA, evaluated systemic exposure to metals detected in tampons against established toxicological safety thresholds. The analysis found that metal concentrations — including potentially hazardous elements such as lead, arsenic, and cadmium — fell well within margins of safety, producing negligible toxicological concern under realistic use scenarios. The assessment modeled exposure based on absorption potential through vaginal mucosa, frequency of use, and duration of contact, producing a more rigorous framework than simple detection-based analyses that report presence without quantifying risk.
This finding is important for several reasons. First, it distinguishes between hazard (a substance being present) and risk (exposure sufficient to cause harm) — a distinction that public concern has frequently collapsed. Detection-based studies, while valuable for identifying contamination signals, are scientifically incomplete without accompanying exposure and dose-response analysis. The FDA's approach here applies standard regulatory toxicology methodology, lending the conclusion considerable institutional weight. That said, limitations deserve acknowledgment: vaginal mucosal absorption rates for specific metals remain incompletely characterized, long-term cumulative exposure modeling carries inherent uncertainty, and this assessment may not capture vulnerable subpopulations such as those with compromised mucosal barriers. The study also does not address potential endocrine-disrupting interactions among co-occurring compounds. Overall, this represents a meaningful regulatory clarification — confirmatory rather than paradigm-shifting — that should help contextualize prior alarm without dismissing the value of continued monitoring.